Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Sumiyoshi

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pathology|July 2, 2018
A family case with germline <i>TSC1</i> and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosisHiromasa Sakamoto, Toshinari Yamasaki, Takayuki Sumiyoshi, et al.
The Pharmacogenomics Journal|March 2, 2021
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancerMasaki Shiota, Shusuke Akamatsu, Shintaro Narita, et al.
International Journal of Clinical Oncology|March 5, 2026
Comprehensive assessment of postoperative quality of life and risk factors after robot-assisted radical prostatectomy using the EPIC questionnaireToru Sakatani, Kimihiko Masui, Toshihiro Magaribuchi, et al.
Cancer Science|May 19, 2021
Detection of von Hippel-Lindau gene mutation in circulating cell-free DNA for clear cell renal cell carcinomaTakayuki Sumiyoshi, Toshinari Yamasaki, Masashi Takeda, et al.
International Journal of Clinical Oncology|March 14, 2012
The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancersYoshiyuki Matsui, Hiroyuki Nishiyama, Koji Yoshimura, et al.
JAMA Network Open|February 23, 2019
Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneMasaki Shiota, Shintaro Narita, Shusuke Akamatsu, et al.
IJU Case Reports|April 20, 2026
A Case of Fulminant Immune-Related Enterocolitis During Immune Checkpoint Inhibitor Therapy for Metastatic Renal Cell CarcinomaKasumi Kanai, Takayuki Sumiyoshi, Hiroki Kitamoto, et al.
Japanese Journal of Radiology|March 14, 2026
Late urinary toxicity after prostate intensity-modulated radiation therapy for patients with history of invasive interventions for prostate or bladderKoichi Kato, Rihito Aizawa, Takashi Ogata, et al.
Asian Journal of Endoscopic Surgery|March 28, 2023
Analysis of trifecta outcomes in a single center with robot-assisted partial nephrectomy for T1b renal tumorsKimihiko Masui, Takashi Matsuoka, Jin Kono, et al.
IJU Case Reports|July 3, 2025
Two-Stage Tumor Resection for Locally Advanced Renal Cell Carcinoma With Level IV Tumor Thrombus and Pulmonary Embolism: A Case ReportTakanari Kambe, Kei Mizuno, Yuki Teramoto, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pathology|July 2, 2018
A family case with germline <i>TSC1</i> and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosisHiromasa Sakamoto, Toshinari Yamasaki, Takayuki Sumiyoshi, et al.
The Pharmacogenomics Journal|March 2, 2021
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancerMasaki Shiota, Shusuke Akamatsu, Shintaro Narita, et al.
International Journal of Clinical Oncology|March 5, 2026
Comprehensive assessment of postoperative quality of life and risk factors after robot-assisted radical prostatectomy using the EPIC questionnaireToru Sakatani, Kimihiko Masui, Toshihiro Magaribuchi, et al.
Cancer Science|May 19, 2021
Detection of von Hippel-Lindau gene mutation in circulating cell-free DNA for clear cell renal cell carcinomaTakayuki Sumiyoshi, Toshinari Yamasaki, Masashi Takeda, et al.
International Journal of Clinical Oncology|March 14, 2012
The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancersYoshiyuki Matsui, Hiroyuki Nishiyama, Koji Yoshimura, et al.
JAMA Network Open|February 23, 2019
Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneMasaki Shiota, Shintaro Narita, Shusuke Akamatsu, et al.
IJU Case Reports|April 20, 2026
A Case of Fulminant Immune-Related Enterocolitis During Immune Checkpoint Inhibitor Therapy for Metastatic Renal Cell CarcinomaKasumi Kanai, Takayuki Sumiyoshi, Hiroki Kitamoto, et al.
Japanese Journal of Radiology|March 14, 2026
Late urinary toxicity after prostate intensity-modulated radiation therapy for patients with history of invasive interventions for prostate or bladderKoichi Kato, Rihito Aizawa, Takashi Ogata, et al.
Asian Journal of Endoscopic Surgery|March 28, 2023
Analysis of trifecta outcomes in a single center with robot-assisted partial nephrectomy for T1b renal tumorsKimihiko Masui, Takashi Matsuoka, Jin Kono, et al.
IJU Case Reports|July 3, 2025
Two-Stage Tumor Resection for Locally Advanced Renal Cell Carcinoma With Level IV Tumor Thrombus and Pulmonary Embolism: A Case ReportTakanari Kambe, Kei Mizuno, Yuki Teramoto, et al.
Pageof 8